$RANI

$0.61 -$0.01 (1.28%) Close

$RANI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 187.2M shares outstanding

Who owns RANI?

By type of holder

Institutions 25.1% Insiders 0.0% Everyone else 74.9%

Concentration Top 10 holders own 58.7%

Mir A Imran 14.5% · InCube Labs, L.L.C. 12.0%

Institutional ownership

25.1%

+1.3 pts vs last qtr

Institutional holders

-14 vs last qtr

Net shares bought

+2.4M

by institutions in Q2 2026

New / sold out

7 / 21

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Polar Asset Management Partners Inc. NEW +2.3M
Samsara Biocapital, LLC +1.9M

Biggest sellers in Q2 2026

SymBiosis Capital Partners, LLC SOLD OUT −3.7M
683 Capital Management, LLC SOLD OUT −487.2K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Rani Therapeutics Holdings Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+238.6%

+35.65% a year

Each share's claim on the business

−70.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $85.2M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years17% 1–3 years7% Under 1 year76%

Quarterly turnover

15.9%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting RANI on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SB Samsara Biocapital, LLC	10.4M	5.54%	+1.9M (+22.0%)	Q4 '25	0.7%
Shares held by quarter Peak holding10.4M (Q2'26) Change over 8 quarters+10.4M Share of the company5.540% Samsara Biocapital, LLC's full portfolio →
RC Ra Capital Management, L.P.	8.5M	4.54%	Unchanged	Q4 '25	0.1%
Shares held by quarter Peak holding8.5M (Q4'25) Change over 8 quarters+8.5M Share of the company4.540% Ra Capital Management, L.P.'s full portfolio →

Samsara Biocapital, LLC

10.4M

% of company

5.54%

Change vs last qtr

+1.9M (+22.0%)

Held since

Q4 '25

Ra Capital Management, L.P.

8.5M

% of company

4.54%

Change vs last qtr

Unchanged

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Rani Therapeutics Holdings Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting RANI on Form N-PORT; together they hold 3.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$2.77M	3.6M	1.95%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$642K	883.2K	0.47%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$2.77M

% of company

1.95%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$642K

% of company

0.47%

% of the fund

0.00%

As of

June 30, 2026

14 more funds behind a free account

See every fund holding Rani Therapeutics Holdings Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MA Mir A Imran 5%+ holder 13D · 22.1%	27.1M	14.48%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.480% Disclosed stake13D · 22.1% View the 13D/G filing →
IL InCube Labs, L.L.C. 5%+ holder 13D · 18.7%	22.4M	11.98%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.980% Disclosed stake13D · 18.7% View the 13D/G filing →

Mir A Imran

5%+ holder13D · 22.1%

27.1M

% of company

14.48%

Change vs last qtr

—

Held since

—

InCube Labs, L.L.C.

5%+ holder13D · 18.7%

22.4M

% of company

11.98%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Rani Therapeutics Holdings Inc.

Comments